TD Cowen Increases GeneDx (NASDAQ:WGS) Price Target to $24.00

GeneDx (NASDAQ:WGS – Get Free Report) had its price target increased by TD Cowen from $14.00 to $24.00 in a research report issued on Tuesday, Benzinga reports. The firm currently has a “buy” rating on the stock. TD Cowen’s target price would indicate a potential upside of 36.67% from the company’s current price. A number […]

Related Keywords

Katherine Stueland ,Kevin Feeley ,Genedx Company Profile ,Thompson Davis ,Goldman Sachs Group ,Hightower Advisors ,Securities Exchange Commission ,Genedx Holdings Corp ,Decheng Capital ,Oracle Investment Management Inc ,Get Free Report ,Exchange Commission ,Investment Management ,Tower Advisors ,Genedx Daily ,Genedx ,Nasdaq Wgs ,Swgs ,Medical ,Boost Price Target ,Td Cowen ,